Skip to content

Seminal Level of Clusterin Before Testicular Sperm Extraction

Seminal Level of Clusterin in Infertile Men as a Predictor for Spermatogenesis Before Testicular Sperm Extraction

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03857828
Enrollment
88
Registered
2019-02-28
Start date
2020-12-16
Completion date
2021-05-01
Last updated
2020-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Azoospermia, Nonobstructive

Brief summary

Measurement of clusterin level in the semen of infertile males undergoing testicular sperm extraction.

Detailed description

Clusterin, known as apolipoprotein J, sulphated glycoprotein-2 or testosterone - repressed prostate message-2. It plays important roles in several pathophysiological processes, including tissue remodelling, lipid transport, reproduction, complement regulation and apoptotic cell death . As clusterin expression is markedly upregulated in various normal and malignant tissues undergoing apoptosis, it has been regarded as a marker for cell death. There is a conflicting findings concerning the relationship between elevated clusterin expression and enhanced induction of apoptosis; that is, clusterin has appeared to have a powerful anti-apoptotic function through a chaperone-like activity. In addition to the anti-apoptotic activity, seminal clusterin was reported to promote a tolerogenic response to male antigens, thereby contributing to female tolerance to seminal antigens. In the testis, clusterin is secreted by Sertoli cells into the fluid of the seminiferous epithelium and deposited onto the membranes of elongating spermatids and mature spermatozoa. To date, however, there has been little information with respect to the functional roles of clusterin in the male reproductive tract under physiological conditions. In particular, it remains controversial as to whether or not clusterin helps assist the normal spermatogenesis. Nonobstructive azoospermia (NOA) males are characterised by impaired spermatogenesis. Although NOA patients have impaired global spermatogenic function, focal areas of spermatogenesis may still exist in their testes. Focal spermatogenesis could possibly be obtained by testicular sperm extraction (TESE) technique . A number of factors have been suggested to be of predictive value for patients with a good chance to retrieve sperm cell such as testicular volume, serum FSH levels , serum total testosterone and serum inhibin B levels.

Interventions

• seminal sample for measuring clusterin level.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
20 Years to 50 Years

Inclusion criteria

* Infertile males , Azoospermia undergoing TESE as a preliminary step for ICSI . * Age: 20-50 year

Exclusion criteria

* males \<20 years and \>50years * Cryptorchidism . * Testicular Agenesis and testicular atrophy .

Design outcomes

Primary

MeasureTime frameDescription
The level of seminal clusterin before testicular sperm Extraction.1 hourMeasurement of seminal clusterin by enzyme-linked immunosorbent assay (ELISA) and correlate them with the outcome of testicular sperm extraction to recognize predictors for spermatogenesis before testicular sperm extraction.

Contacts

Primary ContactAzza Sheshaey, M.B.B.CH
azzaandel@yahoo.com01096906812
Backup ContactEmad Eldien Kamal, Ph.D
01004026100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026